{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-008040","form_type":"8-K","ticker":"PTIX","cik":"0001022899","company_name":"Protagenic Therapeutics, Inc.new","filed_at":"2025-02-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:02.725005+00:00","generated_at":"2026-05-26T05:21:24.769396+00:00","sec_items":["5.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Protagenic Therapeutics reprices outstanding stock options to $0.2655 per share","bullets":["Stockholders approved repricing of options under 2006 and 2016 Equity Incentive Plans.","Original exercise prices ranged from $1.74 to $19.92; repriced to $0.2655 per share.","New exercise price equals closing common stock price on February 21, 2025.","Action intended to retain and incentivize option holders, including officers and employees."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-008040","json":"https://secwatch.observer/filing/0001493152-25-008040.json","markdown":"https://secwatch.observer/filing/0001493152-25-008040.md","text":"https://secwatch.observer/filing/0001493152-25-008040.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1022899/000149315225008040/0001493152-25-008040-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1022899/000149315225008040/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T05:21:24.769396+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}